Spectrogen Pharma
Ticker > Company >

Spectrogen Pharma share price

Spectrogen Pharmachem Ltd.

 698   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year-33.73%
3 YearNA
5 YearNA

Profit Growth

1 Year520.42%
3 YearNA
5 YearNA

ROE%

1 Year58.89%
3 Year26.5%

ROCE %

1 Year22.91%
3 Year8.98%

Debt/Equity

3.376

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 26.5037270262616% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has high Debt to Equity ratio of 3.376.
  • Company has low Interest coverage ratio of 0.
  • Company has negative cash flow from operations of -3.0861.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023
Net Sales 0 12.39 8.21
Total Expenditure 0.01 12.29 7.77
Operating Profit -0.01 0.1 0.44
Other Income 0 0 0
Interest 0 0.04 0.13
Depreciation 0 0.02 0.05
Exceptional Items 0 0 0
Profit Before Tax -0.01 0.04 0.25
Tax 0 0.01 0.07
Net Profit -0.01 0.03 0.18
Adjusted EPS (Rs.) -0.11 0.57 1.24

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.1 0.1 0.28
Total Reserves -0.01 0.02 0.2
Borrowings 0 0 0
Other N/C liabilities 0 0 2.39
Current liabilities 0.02 3.81 3.03
Total Liabilities 0.11 3.93 5.9
Assets
Net Block 0 0.29 0.24
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0 0 0
Loans & Advances 0 0 0
Other N/C Assets 0 0 0
Current Assets 0.11 3.65 5.66
Total Assets 0.11 3.93 5.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 0.04 0.25
Adjustment 0.02 0.05
Changes in Assets & Liabilities -0.87 -3.32
Tax Paid -0.01 -0.08
Operating Cash Flow -0.82 -3.09
Investing Cash Flow -0.31 0.52
Financing Cash Flow 1.1 2.57
Net Cash Flow -0.03 0

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Spectrogen Pharma
X